-
1
-
-
0023924263
-
Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem kunitz-type inhibitory domains
-
Wun T-Z, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ Jr. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. J Biol Chem 1988; 263: 6001-4.
-
(1988)
J Biol Chem
, vol.263
, pp. 6001-6004
-
-
Wun, T.-Z.1
Kretzmer, K.K.2
Girard, T.J.3
Miletich, J.P.4
Broze G.J., Jr.5
-
2
-
-
0028355520
-
Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): Comparison with human TFPI
-
Kamei S, Kamikubo Y-i, Hamuro T, Fujimoto H, Ishihara M, Yonemura H, Miyamoto S, Funatsu A, Enjyoji K-i, Abumiya T, Miyata T, Kato H. Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI. J Biochem 1994; 115: 708-14.
-
(1994)
J Biochem
, vol.115
, pp. 708-714
-
-
Kamei, S.1
Kamikubo, Y.-I.2
Hamuro, T.3
Fujimoto, H.4
Ishihara, M.5
Yonemura, H.6
Miyamoto, S.7
Funatsu, A.8
Enjyoji, K.-I.9
Abumiya, T.10
Miyata, T.11
Kato, H.12
-
3
-
-
0027996258
-
Complementary DNA sequencing of canine tissue factor pathway inhibitor reveals a unique nanomeric repetitive sequence between the second and third kunitz domains
-
Girard TJ, Gailani D, Broze GJ, Jr. Complementary DNA sequencing of canine tissue factor pathway inhibitor reveals a unique nanomeric repetitive sequence between the second and third Kunitz domains. Biochem J 1994; 303: 923-8.
-
(1994)
Biochem J
, vol.303
, pp. 923-928
-
-
Girard, T.J.1
Gailani, D.2
Broze G.J., Jr.3
-
5
-
-
0026523762
-
CDNA cloning and expression of rat tissue factor pathway inhibitor (TFPI)
-
Enjyoji K-i, Emi M, Mukai T, Kato H. cDNA Cloning and Expression of Rat Tissue Factor Pathway Inhibitor (TFPI). J Biochem 1992; 111: 681-7.
-
(1992)
J Biochem
, vol.111
, pp. 681-687
-
-
Enjyoji, K.-I.1
Emi, M.2
Mukai, T.3
Kato, H.4
-
6
-
-
0031909151
-
Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI)
-
Chang J-Y, Monroe DM, Oliver JA, Liles DK, Roberts HR. Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI). Thromb Haemost 1998; 79: 306-9.
-
(1998)
Thromb Haemost
, vol.79
, pp. 306-309
-
-
Chang, J.-Y.1
Monroe, D.M.2
Oliver, J.A.3
Liles, D.K.4
Roberts, H.R.5
-
7
-
-
0024543984
-
Functional significance of the kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor
-
Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, Broze GJ, Jr. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 1989; 338: 518-20.
-
(1989)
Nature
, vol.338
, pp. 518-520
-
-
Girard, T.J.1
Warren, L.A.2
Novotny, W.F.3
Likert, K.M.4
Brown, S.G.5
Miletich, J.P.6
Broze G.J., Jr.7
-
8
-
-
0027363207
-
Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin
-
Wesselschmidt R, Likert K, Huang Z, MacPhail L, Broze GJ, Jr. Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. Blood Coagul Fibrin 1993; 4: 661-9.
-
(1993)
Blood Coagul Fibrin
, vol.4
, pp. 661-669
-
-
Wesselschmidt, R.1
Likert, K.2
Huang, Z.3
MacPhail, L.4
Broze G.J., Jr.5
-
9
-
-
0029004209
-
Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: A segment, Gly212-Phe243, of the third kunitz domain is a heparin-binding site
-
Enjyoji K-i, Miyata T, Kamikubo Y-i, Kato H. Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site. Biochemistry 1995; 34: 5725-35.
-
(1995)
Biochemistry
, vol.34
, pp. 5725-5735
-
-
Enjyoji, K.-I.1
Miyata, T.2
Kamikubo, Y.-I.3
Kato, H.4
-
10
-
-
0022555842
-
Complex transcriptional units: Diversity in gene expression by alternative RNA processing
-
Leff S, Rosenfeld M. Complex transcriptional units: diversity in gene expression by alternative RNA processing. Ann Rev Biochem 1986; 55: 1091-1117.
-
(1986)
Ann Rev Biochem
, vol.55
, pp. 1091-1117
-
-
Leff, S.1
Rosenfeld, M.2
-
11
-
-
0026034658
-
Mechanisms of alternative pre-mRNA splicing
-
Maniatis T. Mechanisms of alternative pre-mRNA splicing. Science 1991; 251: 33-4.
-
(1991)
Science
, vol.251
, pp. 33-34
-
-
Maniatis, T.1
-
12
-
-
0026477884
-
RNA binding proteins, splice site selection, and alternative pre-mRNA splicing
-
Rio D. RNA binding proteins, splice site selection, and alternative pre-mRNA splicing. Gene Expression 1992; 2: 1-5.
-
(1992)
Gene Expression
, vol.2
, pp. 1-5
-
-
Rio, D.1
-
13
-
-
0028307171
-
Split genes and RNA splicing
-
Sharp P. Split genes and RNA splicing. Cell 1994; 77: 805-15.
-
(1994)
Cell
, vol.77
, pp. 805-815
-
-
Sharp, P.1
-
14
-
-
0004043397
-
-
Springer-Verlag, New York
-
Hynes RO. Fibronectins. Springer-Verlag, New York 1990.
-
(1990)
Fibronectins
-
-
Hynes, R.O.1
-
16
-
-
0026668480
-
Tissue factor pathway inhibitor: The carboxy-terminus is required for optimal inhibition of factor Xa
-
Wesselschmidt RL, Likert K, Girard T, Wun T-C, Broze GJ Jr. Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. Blood 1992; 79: 2004-10.
-
(1992)
Blood
, vol.79
, pp. 2004-2010
-
-
Wesselschmidt, R.L.1
Likert, K.2
Girard, T.3
Wun, T.-C.4
Broze G.J., Jr.5
-
17
-
-
0027724106
-
Kinetics of factor Xa inhibition by tissue factor pathway inhibitor
-
Huang Z-F, Wun T-C, Broze GJ, Jr. Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem 1993; 268: 26950-5.
-
(1993)
J Biol Chem
, vol.268
, pp. 26950-26955
-
-
Huang, Z.-F.1
Wun, T.-C.2
Broze G.J., Jr.3
-
18
-
-
0022510143
-
Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins
-
Engelman DM, Steitz TA, Goldman A. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Ann Rev Biophys Biophys Chem 1986; 15: 321-53.
-
(1986)
Ann Rev Biophys Biophys Chem
, vol.15
, pp. 321-353
-
-
Engelman, D.M.1
Steitz, T.A.2
Goldman, A.3
-
19
-
-
0024361685
-
Identification of the 1.4Kb and 4.0 Kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein
-
Girard TJ, Warren LA, Novonty WF, Bejcek BE, Miletich JP, Broze GJ, Jr. Identification of the 1.4Kb and 4.0 Kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein. Thromb Res 1989; 55: 37-50.
-
(1989)
Thromb Res
, vol.55
, pp. 37-50
-
-
Girard, T.J.1
Warren, L.A.2
Novonty, W.F.3
Bejcek, B.E.4
Miletich, J.P.5
Broze G.J., Jr.6
-
20
-
-
0025222311
-
Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: Evidence that endothelium is the principle site of its synthesis
-
Bajaj M, Kuppuswamy M, Satio H, Spitzer S, Bajaj S. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principle site of its synthesis. Proc Natl Acad Sci USA 1990; 87: 8869-73.
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 8869-8873
-
-
Bajaj, M.1
Kuppuswamy, M.2
Satio, H.3
Spitzer, S.4
Bajaj, S.5
-
21
-
-
0030738021
-
Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice
-
Huang Z-F, Huguchi D, Lasky N, Broze GJ, Jr. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 1997; 90: 944-51.
-
(1997)
Blood
, vol.90
, pp. 944-951
-
-
Huang, Z.-F.1
Huguchi, D.2
Lasky, N.3
Broze G.J., Jr.4
-
23
-
-
0028928366
-
Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia
-
Kokawa T, Abumiya T, Kimura T, Harada-Shiba M, Koh H, Tsushima M, Yamamoto A, Kato H. Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein-associated and free forms in hyperlipidemia. Arterioscler. Thromb Vasc Biol 1995; 15: 504-10.
-
(1995)
Arterioscler. Thromb Vasc Biol
, vol.15
, pp. 504-510
-
-
Kokawa, T.1
Abumiya, T.2
Kimura, T.3
Harada-Shiba, M.4
Koh, H.5
Tsushima, M.6
Yamamoto, A.7
Kato, H.8
-
24
-
-
0024434125
-
Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma
-
Novotny WF, Girard TJ, Miletich J P, Broze GJ, Jr. Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. J Biol Chem 1989; 264: 18832-7.
-
(1989)
J Biol Chem
, vol.264
, pp. 18832-18837
-
-
Novotny, W.F.1
Girard, T.J.2
Miletich, J.P.3
Broze G.J., Jr.4
-
25
-
-
0024231919
-
Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor
-
Novotny WF, Girard TJ, Miletich JP, Broze GJ, Jr. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood 1988; 72: 2020-5.
-
(1988)
Blood
, vol.72
, pp. 2020-2025
-
-
Novotny, W.F.1
Girard, T.J.2
Miletich, J.P.3
Broze G.J., Jr.4
-
26
-
-
0027489546
-
Evidence that the C-terminus of tissue factor pathway inhibitor (TFP1) is essential for its in vitro and in vivo interaction with lipoproteins
-
Valentin S, Nordfang O, Bregengard C, Wildgoose P. Evidence that the C-terminus of tissue factor pathway inhibitor (TFP1) is essential for its in vitro and in vivo interaction with lipoproteins. Blood Coag Fibrinol 1993; 4: 713-20.
-
(1993)
Blood Coag Fibrinol
, vol.4
, pp. 713-720
-
-
Valentin, S.1
Nordfang, O.2
Bregengard, C.3
Wildgoose, P.4
-
27
-
-
0025871461
-
Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor
-
Novolny WF, Palmier M, Wun T-C, Broze GJ, Jr. Miletich JP. Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. Blood 1991; 78: 394-400.
-
(1991)
Blood
, vol.78
, pp. 394-400
-
-
Novolny, W.F.1
Palmier, M.2
Wun, T.-C.3
Broze G.J., Jr.4
Miletich, J.P.5
-
28
-
-
0023778170
-
Heparin induces release of extrinsic pathway inhibitor (EPI)
-
Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic pathway inhibitor (EPI). Thromb Res 1988; 50: 803-13.
-
(1988)
Thromb Res
, vol.50
, pp. 803-813
-
-
Sandset, P.M.1
Abildgaard, U.2
Larsen, M.L.3
-
29
-
-
0029122652
-
An anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third kunitz domain (K3) of free-form TFPI but not lipoprotein-associated forms in plasma
-
Abumiya T, Enjyoji K-I, Kokawa T, Kamikubo Y-I, Kato H. An anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third Kunitz domain (K3) of free-form TFPI but not lipoprotein-associated forms in plasma. J. Biochem. 1995; 118: 178-82.
-
(1995)
J. Biochem.
, vol.118
, pp. 178-182
-
-
Abumiya, T.1
Enjyoji, K.-I.2
Kokawa, T.3
Kamikubo, Y.-I.4
Kato, H.5
-
30
-
-
0017384270
-
High density lipoprotein as a protective factor against coronary heart disease. The framingham study
-
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med 1977: 62: 707-14.
-
(1977)
Am J Med
, vol.62
, pp. 707-714
-
-
Gordon, T.1
Castelli, W.P.2
Hjortland, M.C.3
Kannel, W.B.4
Dawber, T.R.5
-
31
-
-
0026036234
-
Lp(a) as a marker for coronary heart disease risk
-
Scanu AM. Lp(a) as a marker for coronary heart disease risk. Clin Cardiol 1991; 14: I-35-9.
-
(1991)
Clin Cardiol
, vol.14
-
-
Scanu, A.M.1
-
32
-
-
0023807047
-
Low-density lipoprotein subclass patterns and risk of myocardial infarction
-
Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC. Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917-21.
-
(1988)
JAMA
, vol.260
, pp. 1917-1921
-
-
Austin, M.A.1
Breslow, J.L.2
Hennekens, C.H.3
Buring, J.E.4
Willett, W.C.5
Krauss, R.M.6
|